Association of Medical Device Reprocessors Celebrates 15 Years of Cutting Healthcare Spending
The Association of Medical Device Reprocessors (AMDR) celebrates a significant milestone today, marking 15 years of helping hospitals cut wasteful spending. Its members saved U.S. hospitals $300 million in 2011 alone. The third-party reprocessing association, which has helped grow reprocessing from a $20 million industry in 2000 to a $400 million industry today, calls for increased adoption and market growth over the next five years.
As governments grapple with how to reduce healthcare costs while maintaining quality of care delivery, the industry has a responsibility to bring forth solutions, says Dan Vukelich, president of AMDR. Reprocessing offers a smart way for hospitals to save up to 50 percent on medical device supply costs with no up-front investment. Were proud of the work our industry has done over the past 15 years, but theres more that can be done in terms of expanding adoption and, in-turn, increasing the cost-savings to the system. We estimate that if just 2 percent of devices marked as single-use could be reprocessed, the healthcare industry would save $2 billion each year.
On top of the significant financial benefit, hospitals can also divert a substantial amount of waste from landfills by implementing a reprocessing program. American hospitals generate over 4 billion pounds of waste annually, making the health industry the second-largest contributor to U.S. landfills. AMDR members helped hospitals divert over 9 million pounds of medical waste from landfills or incinerators in 2011.
The medical device reprocessing industry currently serves most U.S. hospitals, including 16 of the countrys 17 Honor Roll hospitals as ranked by U.S. News & World Report and nine of the top 10 heart hospitals. One of the most telling signs of growth is that the independent companies that originally formed AMDR are now wholly-owned subsidiaries of two respected giants in the medical device industry: Stryker Sustainability Solutions, a division of Stryker Corporation and Sterilmed, Inc., an affiliate of Ethicon Endo-Surgery, Inc. (part of the Johnson & Johnson family of companies).
The entrance of big names like Stryker and Johnson & Johnson into the reprocessing industry underscores the major paradigm shift that is occurring in healthcare: Value-based healthcare is replacing volume-based healthcare with hospitals now more desperate than ever for solutions to reduce waste, maximize the value of their purchasing decisions and promote sustainability. Medical device reprocessing is one of the first programs clinicians employ to immediately cut costs while providing their patients with the same standard of care, adds Vukelich.  Â
Â
Source: Association of Medical Device Reprocessors
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
